Alerts will be sent to your verified email
Verify Email
CHANDAN
|
Chandan Healthcare
|
Oxygenta Pharma
|
Albert David
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.89 % | 10.1 % | 12.32 % |
|
5yr average Equity Multiplier
|
3.38 | -1.22 | 1.67 |
|
5yr Average Asset Turnover Ratio
|
1.41 | 1.1 | 0.67 |
|
5yr Avg Net Profit Margin
|
3.01 % | -16.74 % | 11.52 % |
|
Price to Book
|
0.0 | 0.0 | 1.17 |
|
P/E
|
20.29 | 0.0 | 26.73 |
|
5yr Avg Cash Conversion Cycle
|
-66.59 Days | -56.32 Days | -59.38 Days |
|
Inventory Days
|
23.67 Days | 94.46 Days | 46.72 Days |
|
Days Receivable
|
51.93 Days | 80.66 Days | 28.39 Days |
|
Days Payable
|
184.38 Days | 174.19 Days | 118.01 Days |
|
5yr Average Interest Coverage Ratio
|
4.08 | -3.11 | 90.39 |
|
5yr Avg ROCE
|
19.88 % | -80.86 % | 15.83 % |
|
5yr Avg Operating Profit Margin
|
7.87 % | -18.99 % | 11.27 % |
|
5 yr average Debt to Equity
|
0.83 | -1.55 | 0.01 |
|
5yr CAGR Net Profit
|
n/a | -9.68 % | 31.51 % |
|
5yr Average Return on Assets
|
4.05 % | -10.42 % | 7.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.43 % | 51.12 % | 62.24 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 38.79 % | 0.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
|
Chandan Healthcare
|
Oxygenta Pharma
|
Albert David
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|